Head-To-Head Contrast: RYTHM (RYM) & Its Rivals

RYTHM (NASDAQ:RYM) is one of 906 publicly-traded companies in the “Pharmaceuticals” industry, but how does it weigh in compared to its rivals? We will compare RYTHM to similar businesses based on the strength of its risk, earnings, analyst recommendations, profitability, valuation, dividends and institutional ownership.

Insider & Institutional Ownership

6.0% of RYTHM shares are owned by institutional investors. Comparatively, 32.8% of shares of all “Pharmaceuticals” companies are owned by institutional investors. 3.5% of RYTHM shares are owned by company insiders. Comparatively, 14.2% of shares of all “Pharmaceuticals” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares RYTHM and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
RYTHM	-6.20%	-12.57%	-2.60%
RYTHM Competitors	-2,303.77%	-221.69%	-17.78%

Valuation & Earnings

This table compares RYTHM and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
RYTHM	$17.28 million	-$33.26 million	-2.15
RYTHM Competitors	$3.46 billion	$3.10 billion	549.80

RYTHM’s rivals have higher revenue and earnings than RYTHM. RYTHM is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of recent ratings and recommmendations for RYTHM and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RYTHM	1	0	0	0	1.00
RYTHM Competitors	7718	13662	25546	994	2.41

As a group, “Pharmaceuticals” companies have a potential upside of 30.65%. Given RYTHM’s rivals stronger consensus rating and higher possible upside, analysts plainly believe RYTHM has less favorable growth aspects than its rivals.

Volatility & Risk

RYTHM has a beta of 9.47, indicating that its stock price is 847% more volatile than the S&P 500. Comparatively, RYTHM’s rivals have a beta of -3.18, indicating that their average stock price is 418% less volatile than the S&P 500.

Summary

RYTHM rivals beat RYTHM on 9 of the 13 factors compared.

About RYTHM

Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.